Q32 Bio Inc. (QTTB)
(Delayed Data from NSDQ)
$25.50 USD
-1.85 (-6.76%)
Updated May 31, 2024 04:00 PM ET
After-Market: $25.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -1.00 |
EPS Last Quarter | -13.15 |
Last EPS Surprise | -826.06% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.92 |
Next Year | -4.59 |
EPS (TTM) | -38.69 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.35M | 0.00M | 1.16M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.00 | -1.04 | -3.92 | -4.59 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.93 | -0.99 | -3.72 | -5.18 |
High Estimate | -0.93 | -0.99 | -3.72 | -3.28 |
Low Estimate | -1.05 | -1.08 | -4.08 | -5.31 |
Year ago EPS | -10.97 | -10.25 | -32.73 | -3.92 |
Year over Year Growth Est. | 90.88% | 89.85% | 88.02% | -17.01% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 2 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 0 | 2 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.00 | -1.04 | -3.92 | -4.59 |
7 Days Ago | -1.00 | -1.04 | -3.92 | -4.59 |
30 Days Ago | -0.98 | -1.01 | -4.37 | -3.95 |
60 Days Ago | NA | NA | NA | NA |
90 Days Ago | NA | NA | -13.49 | -12.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.00 | -1.04 | -3.92 | -4.59 |
Zacks Consensus Estimate | -1.00 | -1.04 | -3.92 | -4.59 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -13.15 | -4.32 | -10.25 | -10.97 | NA |
Estimate | -1.42 | NA | -7.55 | -9.17 | NA |
Difference | -11.73 | NA | -2.70 | -1.80 | -5.41 |
Surprise | -826.06% | NA | -35.71% | -19.61% | -293.79% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more